-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NRrLCFvTvsnMsKusH78+BdCWykXnfd754DQemkgkfjuv0zgLqepO2tk56qPn1ptW WGhZ4DWYbRTC6RwJftrsFQ== 0000887777-07-000004.txt : 20070215 0000887777-07-000004.hdr.sgml : 20070215 20070215150926 ACCESSION NUMBER: 0000887777-07-000004 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070215 DATE AS OF CHANGE: 20070215 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DAVENPORT & CO LLC CENTRAL INDEX KEY: 0000887777 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-57489 FILM NUMBER: 07626992 BUSINESS ADDRESS: STREET 1: 901 E CARY STREET STE 1110 CITY: RICHMOND STATE: VA ZIP: 23211 BUSINESS PHONE: 8047802000 MAIL ADDRESS: STREET 1: P O BOX 85678 CITY: RICHMOND STATE: VA ZIP: 23285-5678 FORMER COMPANY: FORMER CONFORMED NAME: DAVENPORT & CO OF VIRGINIA INC DATE OF NAME CHANGE: 20010213 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DAVENPORT & CO LLC CENTRAL INDEX KEY: 0000887777 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 901 E CARY STREET STE 1110 CITY: RICHMOND STATE: VA ZIP: 23211 BUSINESS PHONE: 8047802000 MAIL ADDRESS: STREET 1: P O BOX 85678 CITY: RICHMOND STATE: VA ZIP: 23285-5678 FORMER COMPANY: FORMER CONFORMED NAME: DAVENPORT & CO OF VIRGINIA INC DATE OF NAME CHANGE: 20010213 SC 13G 1 davenport_13gfiling.txt DAVENPORT 13G FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Pharmanetics, Inc. - ----------------------------------------------------------------------- (Name of Issuer) COMMON STOCK - ----------------------------------------------------------------------- (Title of Class of Securities) 71713J107 --------------------------------------- (CUSIP Number) January 31, 2007 - ----------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 6 pages CUSIP No. 71713J107 13G Page 2 of 6 Pages 1. Name of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) Davenport & Company LLC 54-1835842 - ----------------------------------------------------------------------- 2. Check the Appropriate Box If a Member of a Group (See Instructions) (a) [ ] (b) [ ] - ----------------------------------------------------------------------- 3. SEC Use Only - ----------------------------------------------------------------------- 4. Citizenship or Place of Organization Virginia, USA - ----------------------------------------------------------------------- 5. Sole Voting Power NUMBER OF None SHARES -------------------------------------------------------- BENEFICIALLY 6. Shared Voting Power OWNED BY None EACH -------------------------------------------------------- REPORTING 7. Sole Dispositive Power PERSON 20,332 WITH: -------------------------------------------------------- 8. Shared Dispositive Power 1,693,575 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,713,907 - ----------------------------------------------------------------------- 10. Check Box If the Aggregate Amount in Row (9) Excludes Certain Shares [ ] - ----------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 16.0373% - ----------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) HC - ----------------------------------------------------------------------- CUSIP No. 71713J107 13G Page 3 of 6 Pages - ----------------------------------------------------------------------- Item 1(a). Name of Issuer: Pharmanetics, Inc. - ----------------------------------------------------------------------- Item 1(b). Address of Issuer's Principal Executive Offices: 3700 National Drive Raleigh, NC 27612 - ----------------------------------------------------------------------- Item 2(a). Name of Person Filing: Davenport & Company LLC - ----------------------------------------------------------------------- Item 2(b). Address of Principal Business Office, or if None, Residence: One James Center 901 E Cary St Richmond, VA 23219 - ----------------------------------------------------------------------- Item 2(c). Citizenship: VIRGINIA, USA - ----------------------------------------------------------------------- Item 2(d). Title of Class of Securities: COMMON STOCK - ----------------------------------------------------------------------- Item 2(e). CUSIP Number: 71713J107 - ---------------------------------------------------------------------- ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under Section 8 of t he Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [ ] An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with ss. 240.13d-1(b)(1)(ii)(F); (g) [X] A parent holding company or control person in accordance with ss.240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from investment company under section 3(c)(14) of the investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J). ITEM 4. OWNERSHIP. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1,712,907 (b) Percent of class: 16.0373% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote None (ii) Shared power to vote or to direct the vote None (iii) Sole power to dispose or to direct the disposition of 20,332 (iv) Shared power to dispose or to direct the disposition of 1,693,575 INSTRUCTION. For computations regarding securities which represent a right to acquire an underlying security SEE ss.240.13d3(d)(1). - ----------------------------------------------------------------------- ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. - ----------------------------------------------------------------------- ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. - ----------------------------------------------------------------------- ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. - ----------------------------------------------------------------------- ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. - ----------------------------------------------------------------------- ITEM 9. NOTICE OF DISSOLUTION OF GROUP. - ----------------------------------------------------------------------- ITEM 10. CERTIFICATIONS. (a) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(b): "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and not held for the having such purpose or effect." (b) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(c): "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect." SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 15, 2007 --------------------------------- (Date) Denise C. Peters --------------------------------- (Signature) Denise C. Peters, First Vice President ----------------------------------------- (Name/Title) Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties for whom copies are to be sent. Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). -----END PRIVACY-ENHANCED MESSAGE-----